Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.
about
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain proteinNovel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA librariesHuman Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune responseEpirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell ActivityIntratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.Genetic changes occurring in established tumors rapidly stimulate new antibody responsesTherapeutic vaccination with tumor cells that engage CD137.Identification of tumor-associated antigens using proteomics.Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cellsSpecificity in cancer immunotherapy.Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.New targets for the immunotherapy of colon cancer-does reactive disease hold the answer?siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions.Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells.B lymphocytes and cancer: a love-hate relationship.HER2 peptide-specific CD8(+) T cells are proportionally detectable long after multiple DNA vaccinations.NY-ESO-1 protein expression and humoral immune responses in prostate cancer.Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
P2860
Q24531314-CFD37B83-EEFF-4366-9C14-2F80C1E8B3A1Q24648046-A794E241-7FB3-4A2D-BCF3-572FAD180E84Q28178383-F274BC30-ADCB-49D1-AA8C-5FDA01B8E2C3Q28251022-6A06D932-035C-4868-9330-2540B712D5A2Q28550203-A8B6C6A0-AE7E-44A9-8565-930A51D591BEQ33737660-46C3E8E1-BD55-43E9-A34B-6F2375DC4380Q33879089-22B522F0-E6AE-465A-8CA5-93720852082EQ34691545-D8424975-FF21-49F2-9BB5-1FAB0287E682Q34983184-A898128A-9F94-4F54-8FE3-3EBCD98F824EQ35071688-E158103B-DC7B-40BD-8FC3-AF800E5D0C43Q35081121-9E5C6104-D14A-4864-B0AA-83984570C645Q35927479-797F10E8-ABA0-4EC1-9608-4EBF931F0AB7Q35978636-153E152F-DFC1-4A69-905E-99211E365A6EQ36402710-020E19A4-0295-4E8A-9495-DCF408A9DFE5Q37236636-43468EF5-39C4-48E9-A0C8-64BE86B99918Q37383509-A3764F08-981E-441F-8F22-A336D6D5D3EBQ38089480-C6C97271-DD8D-4BD8-A764-F15AD2AF62DAQ39437920-9DFDE951-B349-4FA6-8E4B-2170F4EECA02Q39904256-2EBDBD91-EE16-4BEB-BABF-3A25F339CDC6Q44779139-04ECA35B-51CF-45B1-94CB-25970A3EA20EQ45887207-758DFCC4-4453-4EDE-87E5-DB9E470324F5Q47816351-88851407-1488-4BA1-BF26-5AE296644D70Q53640046-DA50743C-067A-49B9-B369-DE6C59611CE9
P2860
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@ast
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@en
type
label
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@ast
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@en
prefLabel
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@ast
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@en
P2093
P2860
P356
P1476
Role of SEREX-defined immunoge ...... nt of tumor-specific immunity.
@en
P2093
H Nishikawa
K Kuribayashi
M Sakakura
M Watanabe
P2860
P304
14571-14576
P356
10.1073/PNAS.251547298
P407
P577
2001-11-27T00:00:00Z